Johnson & Johnson Portfolio Update

27 October 2022 Dear Valued Partner ACUVUE® PORTFOLIO UPDATE: REDUCTION OF PARAMETER RANGE FOR ACUVUE® OASYS FOR ASTIGMATISM (2-WEEK) At Johnson & Johnson Vision, we strive to support you with vision care solutions that cater for the majority of patients’ vision correction needs.

With the ACUVUE® portfolio of products, we’ve built upon a reputation of reliability, insightful innovation, and an understanding of your patients’ visual challenges to deliver an exceptional contact lens experience.

To ensure we continue to bring innovation to market to better serve your patients, we are implementing decisions on our future portfolio to support the greatest patient needs.

ACUVUE® OASYS for Astigmatism parameters that will no longer be available: Power

Cylinder

Axis

+0.25 to +6.00 (in 0.25 steps)

-2.25D, -2.75D

All axis

-0.75D, -1.25D, -1.75D

30°, 40°, 50°, 60°, 120°, 130°, 140°, 150°

-2.25D, -2.75D

30°, 40°, 50°, 60°, 120°, 130°, 140°, 150°

-1.75D, -2.25D, -2.75D

30°, 40°, 50°, 60°, 70°, 80°, 90°, 100°, 110°, 120°, 130°, 140°, 150°

0.00 to -6.00 (in 0.25 steps) -6.50 to -9.00 (in 0.50 steps)

The above parameters for ACUVUE® OASYS for Astigmatism (2-week) is expected to be available until January 2023 based on current levels of demand, or while supplies last.

Diagnostic lenses for these parameters will no longer be available from 14 November 2022.

From January 2023, the ACUVUE® OASYS (2-week) family of contact lenses will be able to offer 96.4% coverage of spherical and astigmatic eyes.* For more information, please contact your Johnson & Johnson Vision Representative.

Yours sincerely

Michelle Ho Business Unit Director Australia & New Zealand

*JJV Data on file October 2022. Proportion astigmats accommodated with ACUVUE Brand CLs for ASTIGMATISM. C04295 ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE Johnson & Johnson Vision Care (Australia) Pty Ltd, 45 Jones Street, Ultimo. NSW 2007. Australia.

Johnson & Johnson Vision Care, a division of Johnson & Johnson (New Zealand) Ltd, 507 Mt. Wellington Highway, Mt. Wellington. Auckland. 1006. New Zealand. PP2022MLT6726 Page 1

27 October 2022

Dear Valued Partner ACUVUE® PORTFOLIO UPDATE: DISCONTINUATION OF 1-DAY ACUVUE® TRUEYE® To ensure we bring innovation to market to better serve your patients, we are implementing decisions on our future portfolio to support the greatest patient needs.

We are discontinuing the sale of 1-Day ACUVUE® TruEye® brand in Australia and New Zealand to pave the way for innovation that suits the modern lives of today’s patients.

1-Day ACUVUE® TruEye® brand products is expected to be available until April 2023 based on current levels of demand, or while supplies last. Diagnostic lenses for this product will no longer be available from 14 November 2022.

Upgrade your patients to ACUVUE® OASYS 1-Day We recommend upgrading your current 1-Day ACUVUE® TruEye® patients to ACUVUE® OASYS 1-Day contact lenses with HydraLuxe™ Technology. This is a daily contact lens for those who demand high performance, use digital screens frequently, or work in challenging environments, providing sharper, brighter, clearer vision with exceptional comfort.1 In a clinical trial, 9 in 10 patients successfully fit with 1-Day ACUVUE® TruEye® could be successfully fit with ACUVUE OASYS 1-Day2. You and your patients can Take Comfort in ACUVUE.

For more information, please contact your Johnson & Johnson Vision Representative.

Yours sincerely,

Michelle Ho Business Unit Director Australia New Zealand

1. Data on File 2017. Visual Performance of ACUVUE OASYS Brand 1-Day Contact Lenses with HydraLuxe™ Technology - Consumer Use Claims.

2. While the results from the clinical study indicate a high likelihood that a wearer of 1-Day ACUVUE TruEye can be successfully fit into ACUVUE OASYS 1-Day, they do not assure every patient will successfully make the transition. Eye Care Professionals should use their professional judgment to determine the best way for transitioning the patient based on this information. JJV Data on File 2017. Fitting characteristics of 1-Day ACUVUE TruEye and ACUVUE OASYS 1-Day Brand Contact Lenses. Non-dispensing study, n = 48 contact lens wearers in the UK. C00369 3. WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UVblocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.

ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE Johnson & Johnson Vision Care (Australia) Pty Ltd, 45 Jones Street, Ultimo. NSW 2007. Australia.

Johnson & Johnson Vision Care, a division of Johnson & Johnson (New Zealand) Ltd, 507 Mt. Wellington Highway, Mt. Wellington. Auckland. 1006. New Zealand. PP2022MLT6726 Page 2